Serological Testing Market is Set to Boom Worldwide with a USD 7.6 Billion During the Forecast Period 2030

Serological Testing Market analysis report covers detailed value chain analysis of the market. The value chain analysis helps to analyze major upstream raw materials, major equipment’s, manufacturing process, and downstream customer analysis and major distributor analysis are mentioned in the report along with all the drivers and restraints for the market. It presents a comparative detailed analysis of all regional and player segments, offering readers a better knowledge of the areas in which they can place their existing resources and gauging the priority of a particular region in order to boost their standing in the market.

In 2019, as per the Centers for Diseases Control and Prevention, approximately 34,800 new HIV cases were registered in the U.S. Different serology tests are used to identify antibodies or antigens. Some of the most vital applications for the solutions and products that the market players in the market develop include rotavirus infections, therapeutic drug monitoring, HIV, hepatitis, endotoxins, and other infectious diseases.

Data Bridge Market Research analyses that the serological testing market is expected to reach USD 7.6 billion by 2030, which is USD 4.52 billion in 2022, and is expected to undergo a CAGR of 6.70% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Serology tests are used to identify antibodies or antigens. When the body comes in contact with an antigen, the immune system releases antibodies as a defense mechanism and tries to normalize the antigen. In serological testing, such antigens and antibodies are validated for the diagnosis of a specific disease and condition that further helps doctors give proper medical treatment. Serology testing is done by numerous methods such as enzyme-linked immunosorbent assays (ELISAs), hemagglutinin-inhibition tests, flocculation tests, chemiluminescence immunoassays and neutralization tests

Download Exclusive Sample Report (Including Graphs, Charts & Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-serological-testing-market

Serological Testing Market Dynamics

Drivers

Increasing usage of chemiluminescence immunoassay

The market is witnessing a major shift away from the traditional ELISA method and moving towards the use of CLIA. Disease complications have surged the need to detect smaller target molecules, which leads to the emergence of CLIA. It is used in combination with a directly labelling antigen (antibody) and an indicator such as isoluminol, luminol, or an acridinium ester. The increasing  sensitivity and accuracy of chemiluminescence immunoassay over enzyme-linked immunosorbent assay (ELISA) is anticipated to drive the market growth.

Increase in Antibody Test

The antibody test contributes to the market growth. This dominance is due to the benefits of antibody tests and several advancements in the testing of the serological virus. The high demand for other tests such as viral load tests, genotype tests are going to increase in the forecast period because of the improvements and test accuracies and adoption by expert professionals.

Opportunities

Growing Demand of ELISA

ELISA is of great demand and leading the market due to less turnaround time for testing, long self-life of regents, cheap and affordable reagents, a high number of infectious diseases screenings, high specificity, high sensitivity, and ELISA analyzers are inexpensive. Moreover, technological advancement, less complex steps required for performing, high precision screening, and many several key players are contributing to the growth of ELISA testing segment.

Increasing Incidence of Tuberculosis

There has been increasing incidence of TB in the recent years that lead to the growth of the serological testing. India’s TB incidence for the year 2021 is 210 per 100,000 population than the baseline year of 2015. The incidence was 256 per lakh of population in India and there has been an 18% deterioration. TB is the 13th leading cause of death worldwide and the second leading cause of infectious killer after COVID-19.

Global Serological Testing Market Scope

The serological testing market is segmented on the basis of test type, application and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Test Type

Primary Serological Tests

Enzyme Linked Immunosorbent Assay (ELISA)

Immunoflurescent Antibody Technique (IFAT)

Radio Immunoassay (RIA)

Secondary Serological Tests

Agglutination Tests

Complement Fixation Tests (CFT)

Precipitation Tests

Serum Neutralization Tests (SNT)

Toxin-antitoxin Tests

Tertiary Binding Tests

Application

Rotavirus Infections

Hepatitis

HIV

Endotoxins

Therapeutic Drug Monitoring

Other Infectious Diseases

End-user

Hospital and Clinics

Diagnostic Laboratories

Blood Banks

Diagnostic Laboratories

Others

To Get a Detailed Table of Contents (TOC), please Click Here at @ https://www.databridgemarketresearch.com/toc/?dbmr=global-serological-testing-market

Serological Testing Regional Analysis/Insights

The serological testing market is analyzed and market size insights and trends are provided by test type, application and end-user as referenced above.

The countries covered in the serological testing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the serological testing market due to the increasing incidence of infectious diseases, well-established health care infrastructure and rise in number of geriatric population in the region.

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the increase in awareness, and rise in per capita health care expenditure along with huge rate of infectious diseases in developing countries such as India and China.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter’s five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Serological Testing Market Share Analysis

The serological testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to serological testing market.

Some of the major players operating in the serological testing market are:

Serological Research Institute (SERI) (U.K.)

Chembio Diagnostics, Inc (U.S.)

Cellex (U.S.)

Randox Laboratories Ltd (U.K.)

Abbott (U.S.)

Bio-Rad Laboratories Inc. (U.S.)

BD (U.S.)

Thermo Fisher Scientific Inc. (U.S.)

Ortho Clinical Diagnostics (U.S.)

Quest Diagnostics Incorporated (U.S.)

Abcam Plc (U.K.)

F. Hoffmann-La Roche Ltd. (Switzerland)

ELITechGroup (France)

Teleflex Incorporated (U.S.)

Grifols, S.A. (U.S.)

Global Scientific Company (India)

Beckman Coulter, Inc. (U.S.)

BIOMEDOMICS INC. (U.S.)

Creative Diagnostics (U.S.)

Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-serological-testing-market

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Top Trendings Reports:-

https://www.databridgemarketresearch.com/reports/global-cytomegalovirus-retinitis-market

https://www.databridgemarketresearch.com/reports/global-kaposi-sarcoma-market

https://www.databridgemarketresearch.com/reports/global-retinal-biologics-market

https://www.databridgemarketresearch.com/reports/global-nucleic-acid-amplification-market

https://www.databridgemarketresearch.com/reports/asia-pacific-beauty-devices-market

About Data Bridge Market Research, Private Ltd

Data Bridge Market Research Pvt Ltd is a multinational management consulting firm with offices in India and Canada. As an innovative and neoteric market analysis and advisory company with unmatched durability levels and advanced approaches. We are committed to uncovering the best consumer prospects and fostering useful knowledge for your company to succeed in the market.
Data Bridge Market Research is a result of sheer wisdom and practice that was conceived and built-in Pune in the year 2015. The company came into existence from the healthcare department with far fewer employees intending to cover the whole market while providing the best class analysis. Later, the company widened its departments, as well as expanded its reach by opening a new office in the Gurugram location in the year 2018, where a team of highly qualified personnel joins hands for the growth of the company. “Even in the tough times of COVID-19 where the Virus slowed down everything around the world, the dedicated team of Data Bridge Market Research worked round the clock to provide quality and support to our client base, which also tells about the excellence in our sleeve.”

Contact us:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Corporatesales@databridgemarketresearch.com